Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Anthracycline in Adult ALL (GIMEMA LAL 0496)
NCT00439920Phase 2Unknown
- Sponsor
- GIMEMA
- Start
- Oct 1996
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of daunorubicin in acute lymphoblastic leukemia (ALL), sponsored by GIMEMA. Primary endpoint: Complete Response. Status: unknown.
02
Drugs
daunorubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00439920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439920.